menu
    • menu

    Company profile for HanchorBio

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HanchorBio is dedicated to developing biological medicines with simultaneous multi-targeting through its novel IgG Fc-Based Designer Biologics (FBDB™) platform. With a culture rooted in innovation, quality, and speed, our vision is to be a pioneering biotech company transforming drug development with novel biologic modalities. Our mission is to transcend immuno-oncology therapeutics by creating cutting-edge designer biologic...
    HanchorBio is dedicated to developing biological medicines with simultaneous multi-targeting through its novel IgG Fc-Based Designer Biologics (FBDB™) platform. With a culture rooted in innovation, quality, and speed, our vision is to be a pioneering biotech company transforming drug development with novel biologic modalities. Our mission is to transcend immuno-oncology therapeutics by creating cutting-edge designer biologics with innovative modalities to improve the lives of cancer patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HanchorBioTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    5F, No. 1, Sec. 1, Tiding Blvd., Neihu Dist., Taipei City 114
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hanchorbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hanchorbio Chooses Bloomberg For Enhanced Drug Development
    Hanchorbio Chooses Bloomberg For Enhanced Drug Development

    24 Apr 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/hanchorbio-selects-bloomberg-to-strengthen-its-strategic-intelligence-across-drug-development-and-global-biopharma-302751575.html

    PR NEWSWIRE BIO
    24 Apr 2026
    Share Share
    HanchorBio Advances Toward TWSE Innovation Board Listing
    HanchorBio Advances Toward TWSE Innovation Board Listing

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanchorbio-advances-toward-twse-innovation-board-listing-to-accelerate-global-clinical-development-platform-expansion-and-international-partnering-302724147.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    HanchorBio Receives FDA Orphan Drug for HCB101 in Gastric Cancer
    HanchorBio Receives FDA Orphan Drug for HCB101 in Gastric Cancer

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanchorbio-receives-fda-orphan-drug-designation-for-hcb101-in-gastric-cancer-302687341.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    Hanchorbio, Wuxi Biologics Partner To Advance Fusion Protein
    Hanchorbio, Wuxi Biologics Partner To Advance Fusion Protein

    26 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/hanchorbio-and-wuxi-biologics-enter-strategic-partnership-to-advance-next-generation-bi-and-multi-functional-fusion-protein-pipeline-302669807.html

    PR NEWSWIRE BIO
    26 Jan 2026
    Share Share
    Hanchorbio Presents HCB101 Orally At ESMO Immuno-Oncology
    Hanchorbio Presents HCB101 Orally At ESMO Immuno-Oncology

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanchorbio-announces-oral-presentation-of-hcb101-at-the-esmo-immuno-oncology-congress-2025-302637764.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    HanchorBio Shows Late-Breaking HCB101 Data At SITC 2025
    HanchorBio Shows Late-Breaking HCB101 Data At SITC 2025

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanchorbio-presents-two-late-breaking-abstracts-at-the-society-for-immunotherapy-of-cancer-2025-demonstrating-best-in-class-potential-of-hcb101-in-advanced-cancers-302606530.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search